| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70374 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF229-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB229-SP | |||
| Carrier Free | FAB229V-100UG | |||
| Carrier Free | FAB229U-100UG | |||
| Carrier Free | FAB229T-100UG | |||
| Carrier Free | FAB229S-100UG | |||
| Carrier Free | FAB229R-100UG | |||
| Carrier Free | FAB229N-100UG | |||
| Carrier Free | FAB229G-100UG | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF852-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB8521-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB2291-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52682-0.025mg | |||
![Western Blot: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TNFRSF8.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Western-Blot-NBP2-46157-img0021.jpg "Western Blot: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TNFRSF8.")
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Human endometrium tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0020.jpg)
![Flow Cytometry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - (Blue).(1:100)](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Flow-Cytometry-NBP2-46157-img0022.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Human lymphoma tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0001.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Carcinoma of Human kidney tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0002.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Human lung tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0003.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Adenocarcinoma of Human ovary tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0004.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Carcinoma of Human bladder tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0005.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Human prostate tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0006.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Human bladder tissue..](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0007.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Human Kidney tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0008.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Adenocarcinoma of Human breast tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0009.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Carcinoma of Human liver tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0010.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Human Ovary tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0011.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Human pancreas tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0012.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Carcinoma of Human thyroid tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0013.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Human colon tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0014.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Human lymph node tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0015.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Adenocarcinoma of Human endometrium tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0016.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Adenocarcinoma of Human colon tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0017.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Human thyroid tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0018.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (1C6) [NBP2-46157] - Analysis of Carcinoma of Human prostate tissue.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-1C6-Immunohistochemistry-NBP2-46157-img0019.jpg)
![Western Blot: CD30/TNFRSF8 Antibody (BLR055F) [NBP2-76365] - Detection of human CD30 by WB of MJ, SR, C5/MJ, GaMG, U2OS and A-549 cells. Antibody: Rabbit anti-CD30 recombinant monoclonal [BLR055F] (NBP2-76365). Secondary: HRP-conjugated goat anti-rabbit IgG.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-BLR055F-Western-Blot-NBP2-76365-img0003.jpg "Western Blot: CD30/TNFRSF8 Antibody (BLR055F) [NBP2-76365] - Detection of human CD30 by WB of MJ, SR, C5/MJ, GaMG, U2OS and A-549 cells. Antibody: Rabbit anti-CD30 recombinant monoclonal [BLR055F] (NBP2-76365). Secondary: HRP-conjugated goat anti-rabbit IgG.")
![Immunocytochemistry/Immunofluorescence: CD30/TNFRSF8 Antibody (BLR055F) [NBP2-76365] - Detection of human CD30 (red) in FFPE tonsil by IHC-IF. Antibody: Rabbit anti-CD30 recombinant monoclonal [BLR055F] NBP2-76365. Secondary: HRP-conjugated goat anti-rabbit IgG. Substrate: Opal™. Counterstain: DAPI (blue).](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-BLR055F-Immunocytochemistry-Immunofluorescence-NBP2-76365-img0004.jpg)
![Immunohistochemistry: CD30/TNFRSF8 Antibody (BLR055F) [NBP2-76365] - Antibody: Rabbit anti-CD30 recombinant monoclonal [BLR055F] (NBP2-76365). Secondary: HRP-conjugated goat anti-rabbit IgG. Substrate: DAB.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-BLR055F-Immunohistochemistry-NBP2-76365-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: CD30/TNFRSF8 Antibody (BLR055F) [NBP2-76365] - Detection of human CD30 in FFPE SR cells by ICC. Antibody: Rabbit anti-CD30 recombinant monoclonal [BLR055F] (NBP2-76365). Secondary: HRP-conjugated goat anti-rabbit IgG. Substrate: DAB.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-BLR055F-Immunocytochemistry-NBP2-76365-img0002.jpg)
![N/A CD30/TNFRSF8 [Biotin]](http://images.novusbio.com/fullsize2/DATA_CD30_DY612605_ELISA_2488.jpg "N/A CD30/TNFRSF8 [Biotin]")
![N/A CD30/TNFRSF8 [Biotin]](http://images.novusbio.com/fullsize2/DATA_CD30_DY852_ELISA_2245.jpg "N/A CD30/TNFRSF8 [Biotin]")
![Immunohistochemistry: CD30/TNFRSF8 Antibody (Ki-3) - Chimeric [NBP2-52682] - Immunohistochemical staining of human tonsil tissue using anti-CD30 antibody. Ki-3 Anti-CD30 staining of paraffin embedded human tonsil tissue using the rabbit-chimeric version of Ki-3 (NBP2-52682). Antigen retreival was acheived by microwaving in citrate buffer, followed by blocking with protein block serum-free buffer. Primary antibody incubation with NBP2-52682 was carried out at 4 ug/ml for 30 minutes. Samples were then incubated with an anti-rabbit IgG HRP secondary antibody for 20 mins followed by DAB (3,3'-diaminobenzidine), and counter-staining with haemotoxylin. Staining of the cellular membrane of dividing cells may be observed. Recommended concentration, 2-4 ug/ml.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-Ki-3-Chimeric-Immunohistochemistry-NBP2-52682-img0001.jpg "Immunohistochemistry: CD30/TNFRSF8 Antibody (Ki-3) - Chimeric [NBP2-52682] - Immunohistochemical staining of human tonsil tissue using anti-CD30 antibody. Ki-3 Anti-CD30 staining of paraffin embedded human tonsil tissue using the rabbit-chimeric version of Ki-3 (NBP2-52682). Antigen retreival was acheived by microwaving in citrate buffer, followed by blocking with protein block serum-free buffer. Primary antibody incubation with NBP2-52682 was carried out at 4 ug/ml for 30 minutes. Samples were then incubated with an anti-rabbit IgG HRP secondary antibody for 20 mins followed by DAB (3,3'-diaminobenzidine), and counter-staining with haemotoxylin. Staining of the cellular membrane of dividing cells may be observed. Recommended concentration, 2-4 ug/ml.")
![Flow Cytometry: CD30/TNFRSF8 Antibody (Ki-3) - Chimeric [NBP2-52682] - Flow-cytometry using the anti-CD30 (Tumor necrosis factor receptor superfamily member 8) antibody Ki-3. Jurkat cells were stained with unimmunized rabbit IgG antibody (black line) or the rabbit-chimeric version of Ki-3 (NBP2-52682, blue line) at a concentration of 10 ug/ml for 30 mins at RT. After washing, bound antibody was detected using an anti-rabbit IgG JK (FITC-conjugate) antibody at 2 ug/ml and cells analyzed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-Ki-3-Chimeric-Flow-Cytometry-NBP2-52682-img0002.jpg)
![Western Blot: CD30/TNFRSF8 Antibody (PSH04-12) [NBP3-32144] - Western blot analysis of CD30/TNFRSF8 on different lysates with Rabbit anti-CD30/TNFRSF8 antibody (NBP3-32144) at 1/1,000 dilution. Lane 1: HDLM-2 cell lysate Lane 2: HUT 102 cell lysate Lane 3: U-937 cell lysate (negative) Lane 4: HL-60 cell lysate (negative) Lane 5: Daudi cell lysate (negative) Lane 6: HeLa cell lysate (negative) Lysates/proteins at 20 ug/Lane. Predicted band size: 64 kDa Observed band size: 75-120 kDa Exposure time: 1 minute 2 seconds; 4-20% SDS-PAGE gel. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (NBP3-32144) at 1/1,000 dilution was used in 5% NFDM/TBST at 4C overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody at 1/50,000 dilution was used for 1 hour at room temperature.](http://images.novusbio.com/fullsize/nbp3-32144_rabbit-cd30-tnfrsf8-mab-psh04-12-27820241631646.jpg "Western Blot: CD30/TNFRSF8 Antibody (PSH04-12) [NBP3-32144] - Western blot analysis of CD30/TNFRSF8 on different lysates with Rabbit anti-CD30/TNFRSF8 antibody (NBP3-32144) at 1/1,000 dilution. Lane 1: HDLM-2 cell lysate Lane 2: HUT 102 cell lysate Lane 3: U-937 cell lysate (negative) Lane 4: HL-60 cell lysate (negative) Lane 5: Daudi cell lysate (negative) Lane 6: HeLa cell lysate (negative) Lysates/proteins at 20 ug/Lane. Predicted band size: 64 kDa Observed band size: 75-120 kDa Exposure time: 1 minute 2 seconds; 4-20% SDS-PAGE gel. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (NBP3-32144) at 1/1,000 dilution was used in 5% NFDM/TBST at 4C overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody at 1/50,000 dilution was used for 1 hour at room temperature.")
![Immunohistochemistry: CD30/TNFRSF8 Antibody (PSH04-12) [NBP3-32144] - Immunohistochemical analysis of paraffin-embedded human anaplastic large cell lymphoma tissue with Rabbit anti-CD30/TNFRSF8 antibody (NBP3-32144) at 1/1,500 dilution. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (NBP3-32144) at 1/1,500 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.](http://images.novusbio.com/fullsize/nbp3-32144_rabbit-cd30-tnfrsf8-mab-psh04-12-29820241492678.jpg)
![Immunocytochemistry/ Immunofluorescence: CD30/TNFRSF8 Antibody (PSH04-12) [NBP3-32144] - Immunocytochemistry analysis of HDLM-2 (positive) and HeLa (negative) labeling CD30/TNFRSF8 with Rabbit anti-CD30/TNFRSF8 antibody (NBP3-32144) at 1/100 dilution. Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-CD30/TNFRSF8 antibody (NBP3-32144) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI. Beta tubulin (red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594) was used as the secondary antibody at 1/1,000 dilution.](http://images.novusbio.com/fullsize/nbp3-32144_rabbit-cd30-tnfrsf8-mab-psh04-12-2920241192361.jpg)